Format

Send to

Choose Destination
J Exp Med. 2019 Feb 4;216(2):247-250. doi: 10.1084/jem.20182287. Epub 2019 Jan 16.

Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance.

Author information

1
Novartis Institutes for BioMedical Research, Basel, Switzerland jose.carballido@novartis.com.
2
Julia McFarlane Diabetes Research Centre and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada psantama@ucalgary.ca.
3
Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Abstract

José M. Carballido, Executive Director at Novartis Institutes for BioMedical Research, and Pere Santamaria, Professor of Immunology at the University of Calgary and Founder of Parvus Therapeutics Inc., discuss the opportunities and challenges of translating antigen-specific approaches for autoimmunity with an emphasis on the need for scientific rigor in the preclinical stage.

PMID:
30651299
PMCID:
PMC6363422
[Available on 2019-08-04]
DOI:
10.1084/jem.20182287

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center